Free Trial

Seneca Growth Capital VCT Interim Earnings Report

GBX 49.50 0.00 (0.00%)
As of 02/21/2025

Seneca Growth Capital VCT EPS Results

Actual EPS
-GBX 0.10
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Seneca Growth Capital VCT Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Seneca Growth Capital VCT Announcement Details

Quarter
Interim
Time
After Market Closes

Conference Call Resources

Seneca Growth Capital VCT Earnings Headlines

Seneca Growth Capital VCT PLC B (SVCT)
Seneca Growth Capital VCT B (SVCT.L)
Alert: DOGE goes live
"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what he might do next. And one widely followed Boston based think tank is stepping forward with their official playbook.
B Share Net Asset Value
B Share Buy-back and Total Voting Rights
See More Seneca Growth Capital VCT Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Seneca Growth Capital VCT? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Seneca Growth Capital VCT and other key companies, straight to your email.

About Seneca Growth Capital VCT

Seneca Growth Capital VCT (LON:SVCT) is a venture capital trust specializes in growth capital. It invests in emerging biotechnology companies. It prefers to invest in unquoted and quoted MedTech companies. The fund seeks to invest in the United Kingdom, IIe-de-France, Burgundy, France, European Developed Markets. It typically invests in companies with sales greater than £10 million ($11.90 million), gross margin greater than 50% and operating margin greater than 10%.

View Seneca Growth Capital VCT Profile

More Earnings Resources from MarketBeat